Initiator Pharma A/S
STO:INIT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.35
10.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one INIT stock under the Base Case scenario is 11.12 SEK. Compared to the current market price of 7.35 SEK, Initiator Pharma A/S is Undervalued by 34%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Initiator Pharma A/S
Run backtest to discover the historical profit from buying and selling INIT based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Initiator Pharma A/S
Balance Sheet Decomposition
Initiator Pharma A/S
Current Assets | 20.2m |
Cash & Short-Term Investments | 14.5m |
Receivables | 5.7m |
Non-Current Assets | 17k |
PP&E | 17k |
Current Liabilities | 1.3m |
Accounts Payable | 314k |
Accrued Liabilities | 868k |
Other Current Liabilities | 130k |
Earnings Waterfall
Initiator Pharma A/S
Revenue
|
0
DKK
|
Operating Expenses
|
-18m
DKK
|
Operating Income
|
-18m
DKK
|
Other Expenses
|
1.1m
DKK
|
Net Income
|
-16.9m
DKK
|
Free Cash Flow Analysis
Initiator Pharma A/S
DKK | |
Free Cash Flow | DKK |
INIT Profitability Score
Profitability Due Diligence
Initiator Pharma A/S's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Initiator Pharma A/S's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
INIT Solvency Score
Solvency Due Diligence
Initiator Pharma A/S's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Initiator Pharma A/S's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INIT Price Targets Summary
Initiator Pharma A/S
According to Wall Street analysts, the average 1-year price target for INIT is 24.48 SEK with a low forecast of 24.24 SEK and a high forecast of 25.2 SEK.
Shareholder Yield
Current shareholder yield for INIT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
INIT Price
Initiator Pharma A/S
Average Annual Return | 8.02% |
Standard Deviation of Annual Returns | 52.15% |
Max Drawdown | -60% |
Market Capitalization | 412m SEK |
Shares Outstanding | 52 918 200 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.
Officers
The intrinsic value of one INIT stock under the Base Case scenario is 11.12 SEK.
Compared to the current market price of 7.35 SEK, Initiator Pharma A/S is Undervalued by 34%.